ReviewCurrent gastroenterology reports1999
Update on diagnosis and management of chronic pancreatitis.
Review in Current gastroenterology reports, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 24 citations in OpenAlex.
- Advances in MRI of Chronic Pancreatitis.Advances in clinical radiology · 2024Article
- Detection of exocrine dysfunction by MRI in patients with early chronic pancreatitis.Abdominal radiology (New York) · 2017Article
- Defining the accuracy of secretin pancreatic function testing in patients with suspected early chronic pancreatitis.The American journal of gastroenterology · 2013Article
- Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States.Alimentary pharmacology & therapeutics · 2011Article
- A proposal for a new clinical classification of chronic pancreatitis.BMC gastroenterology · 2009Article
- Pancreatic function testing: here to stay for the 21st century.World journal of gastroenterology · 2008Review
- Diagnosis and management of chronic pancreatitis.Postgraduate medical journal · 2005Review
- Medical therapy for chronic pancreatitis pain.Current gastroenterology reports · 2003Article
Corrections and comments
- Commented on by
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic pancreatitis should be considered in all patients with unexplained abdominal pain. The importance of small duct disease without obvious radiographic abnormalities is an important new concept. It is meaningful for the clinician to define whether the patient with chronic pancreatitis has small duct or large duct disease. Diagnostic evaluations should begin with a simple, noninvasive, inexpensive test such as serum trypsinogen, to be followed by more complicated testing such as the secretin stimulation test, particularly in those patients with small duct disease. Non-enteric-coated pancreatic enzyme preparations are preferred for the treatment of pain whereas enteric-coated pancreatic enzyme preparations are the drugs of choice for treating steatorrhea. Octreotide may become an important therapy for treating abdominal pain unresponsive to pancreatic enzyme therapy. Endoscopic treatment of the pain of chronic pancreatitis should be used only in highly selected patients and may cause damage to the pancreas. Surgical ductal decompression is appropriate in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.